Rep. Kevin Hern Unloads Shares of Waters Corporation (NYSE:WAT)

Posted by Francis Steltz on Sep 3rd, 2026

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Waters Corporation (NYSE:WAT). In a filing disclosed on September 01st, the Representative disclosed that they had sold between $1,001 and $15,000 in Waters stock on August 13th. The trade occurred in the Representative’s “HERN FAMILY REVOCABLE TRUST” account.

Representative Kevin Hern also recently made the following trade(s):

Sold $1,001 – $15,000 in shares of Marsh & McLennan Companies (NYSE:MRSH) on 8/24/2026.
Sold $15,001 – $50,000 in shares of Medtronic (NYSE:MDT) on 8/24/2026.
Sold $50,001 – $100,000 in shares of Home Depot (NYSE:HD) on 8/24/2026.
Sold $50,001 – $100,000 in shares of Procter & Gamble (NYSE:PG) on 8/24/2026.
Sold $1,001 – $15,000 in shares of Lowe’s Companies (NYSE:LOW) on 8/24/2026.
Sold $15,001 – $50,000 in shares of Microsoft (NASDAQ:MSFT) on 8/21/2026.
Sold $1,001 – $15,000 in shares of Veralto (NYSE:VLTO) on 8/21/2026.
Sold $15,001 – $50,000 in shares of Honeywell Aerospace (NASDAQ:HONA) on 8/19/2026.
Sold $1,001 – $15,000 in shares of Colgate-Palmolive (NYSE:CL) on 8/19/2026.
Sold $1,001 – $15,000 in shares of Biogen (NASDAQ:BIIB) on 8/18/2026.

Waters Trading Up 1.6%

Waters stock opened at $412.15 on Thursday. Waters Corporation has a 52 week low of $282.77 and a 52 week high of $426.22. The company has a quick ratio of 1.29, a current ratio of 1.86 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $40.49 billion, a price-to-earnings ratio of 102.78, a price-to-earnings-growth ratio of 2.36 and a beta of 1.19. The stock has a 50-day moving average price of $390.51 and a 200 day moving average price of $350.41.

Waters (NYSE:WAT – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, beating the consensus estimate of $3.01 by $0.04. Waters had a net margin of 3.58% and a return on equity of 11.27%. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.62 billion. During the same period in the prior year, the firm earned $2.95 EPS. The business’s revenue for the quarter was up 113.3% on a year-over-year basis. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Sell-side analysts anticipate that Waters Corporation will post 14.56 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have commented on WAT. Wells Fargo & Company upped their price objective on Waters from $370.00 to $400.00 and gave the stock an “equal weight” rating in a research report on Wednesday, August 5th. Royal Bank Of Canada lifted their price target on Waters from $435.00 to $475.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. The Goldman Sachs Group increased their price objective on shares of Waters from $380.00 to $425.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $400.00 price target on shares of Waters in a research report on Wednesday, August 5th. Finally, UBS Group raised their target price on Waters from $330.00 to $375.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Three analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $424.35.

Read Our Latest Stock Report on Waters

Insiders Place Their Bets

In other news, Director Christopher A. Kuebler sold 3,626 shares of Waters stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the transaction, the director owned 17,808 shares of the company’s stock, valued at $7,086,515.52. The trade was a 16.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 0.31% of the company’s stock.

Institutional Investors Weigh In On Waters

Several institutional investors have recently added to or reduced their stakes in WAT. Anchor Investment Management LLC acquired a new position in shares of Waters in the 1st quarter valued at $27,000. Resources Management Corp CT ADV acquired a new stake in shares of Waters in the 1st quarter worth $27,000. PenderFund Capital Management Ltd. acquired a new position in Waters during the 2nd quarter worth approximately $28,000. Zions Bancorporation National Association UT grew its holdings in Waters by 121.2% during the fourth quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 40 shares during the period. Finally, Vision Retirement LLC purchased a new position in shares of Waters in the 1st quarter valued at about $29,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.

Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.

Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

About Waters

(Get Free Report)

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.